natgillin/translations-raw huggingface dataset:
On 5 May 2014, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 and improvement of bowel function by increasing stool frequency.
Komisija i države članice primile su 5. svibnja 2014. znanstveno mišljenje Agencije koja je zaključila da na temelju dostavljenih podataka nije utvrđena uzročno-posljedična veza između uzimanja kombinacije Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 i Streptococcus thermophilus LA 104 i poboljšanja rada crijeva zahvaljujući učestalijoj stolici.
Following an application from DoubleGood AB, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 and including a request for protection of proprietary data, the Authority was required to deliver an opinion on a health claim related to the effect of a combination of L-threonine, L-valine, L-leucine, L-isoleucine, L-lysine plus chromium picolinate and reduction of post-prandial glycaemic responses (Question No EFSA-Q-2013-00756 [8]).
Na temelju zahtjeva koji je DoubleGood AB podnio u skladu s člankom 13. stavkom 5. Uredbe (EZ) br. 1924/2006 te koji je sadržavao i zahtjev za zaštitu vlasničkih podataka, od Agencije je zatraženo mišljenje o zdravstvenoj tvrdnji u vezi s učinkom kombinacije L-treonina, L-valina, L-leucina, L-izoleucina, L-lizina i kromova pikolinata te smanjenjem glikemijskog odgovora nakon obroka (Predmet br. EFSA-Q-2013-00756 [8]).
The claim proposed by the applicant was worded as follows: ‘Contributes to the reduction of the blood glucose rise when consumed together with a carbohydrate rich meal’.
Tvrdnja koju je predložio podnositelj zahtjeva glasila je: „Pridonosi smanjenju porasta glukoze u krvi ako se uzima s jelom bogatim ugljikohidratima”.
On 16 July 2014, the Commission and the Member States received the scientific opinion from the Authority, in which it was stated that the applicant did not provide any evidence that a reduction in post-prandial blood glucose responses achieved by an increase in insulin secretion is a beneficial physiological effect.
Komisija i države članice primile su 16. srpnja 2014. znanstveno mišljenje Agencije u kojem je navedeno da podnositelj zahtjeva nije pružio nikakve dokaze da smanjenje odgovora glukoze u krvi nakon obroka koje se postiže povećanjem lučenja inzulina ima povoljan fiziološki učinak.
Consequently, the Authority concluded that, on the basis of the data presented, a cause and effect relationship had not been established between the consumption of the food, a combination of L-threonine, L-valine, L-leucine, L-isoleucine, L-lysine plus chromium picolinate, which is the subject of the health claim, and a beneficial physiological effect.
Stoga je Agencija zaključila da na temelju dostavljenih podataka nije utvrđena uzročno-posljedična veza između uzimanja hrane, kombinacije L-treonina, L-valina, L-leucina, L-izoleucina, L-lizina i kromova pikolinata koja je predmet zdravstvene tvrdnje i povoljnog fiziološkog učinka.
Following an application from DSM Nutritional Products and Kemin Foods, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 and including a request for protection of proprietary data, the Authority was required to deliver an opinion on a health claim related to the effect of a combination of lutein and zeaxanthin and improved vision under bright light conditions (Question No EFSA-Q-2013-00875 [9]).
Na temelju zahtjeva koji su DSM Nutritional Products i Kemin Foods podnijeli u skladu s člankom 13. stavkom 5. Uredbe (EZ) br. 1924/2006 te koji je sadržavao i zahtjev za zaštitu vlasničkih podataka, od Agencije je zatraženo mišljenje o zdravstvenoj tvrdnji u vezi s učinkom kombinacije luteina i zeaksantina te poboljšanjem vida na jarkoj svjetlosti (Predmet br. EFSA-Q-2013-00875 [9]).
The claim proposed by the applicants was worded as follows: ‘Lutein together with zeaxanthin helps maintain clarity and contrast of sight in bright light conditions’.
Tvrdnja koju su predložili podnositelji zahtjeva glasila je: „Lutein u kombinaciji s zeaksantinom olakšava održavanje bistrine i kontrasta vida pri jarkoj svjetlosti”.
On 16 July 2014, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of a combination of lutein and zeaxanthin and improved vision under bright light conditions.
Komisija i države članice primile su 16. srpnja 2014. znanstveno mišljenje Agencije koja je zaključila da na temelju dostavljenih podataka nije utvrđena uzročno-posljedična veza između uzimanja kombinacije luteina i zeaksantina te poboljšanja vida na jarkoj svjetlosti.
EFSA Journal 2014;12(5):3650.
EFSA Journal 2014; 12(5):3650.
EFSA Journal 2012;10(5):2699.
EFSA Journal 2012; 10(5):2699.
EFSA Journal 2014;12(5):3655.
EFSA Journal 2014; 12(5):3655.
EFSA Journal 2014;12(5):3656.
EFSA Journal 2014; 12(5):3656.
EFSA Journal 2014;12(5):3658.
EFSA Journal 2014; 12(5):3658.
EFSA Journal 2014;12(5):3659.
EFSA Journal 2014; 12(5):3659.
EFSA Journal 2014;12(7):3752.
EFSA Journal 2014; 12(7):3752.
EFSA Journal 2014;12(7):3753.
EFSA Journal 2014; 12(7):3753.
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.
Članak 13. stavak 5. – zdravstvena tvrdnja koja se temelji na novim znanstvenim dokazima i/ili uključuje zahtjev za zaštitu vlasničkih podataka.
Maintenance of ATP levels through reduction of lactates in excess for an improved recovery from muscle fatigue.
Održavanje razina ATP-a smanjenjem viška laktata radi bržeg oporavka od mišićnog umora.
Olive (Olea europaea L.) leaf water extract
Vodeni ekstrakt lista masline (Olea europaea L.)
Daily intake of supplemental olive leaf extract polyphenols contributes to the reduction of the blood glucose rise after meals.
Svakodnevni unos polifenola ekstrakta lista masline kao dodatka prehrani pridonosi smanjenju porasta glukoze u krvi nakon jela.
Pacran® helps to inhibit the adhesion of P-fimbriated E. coli to the urinary tract cells.
Pacran® pomaže inhibiciji adhezije bakterije E. coli s P-fimbrijama za stanice urinarnog trakta.
A combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104
Kombinacija Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 i Streptococcus thermophilus LA 104
Improves intestinal comfort.
Poboljšava rad crijeva.
Regulates your (intestinal) transit.
Regulira prolazak (crijevnog) sadržaja.
A combination of L-threonine, L-valine, L-leucine, L-isoleucine, L-lysine plus chromium picolinate
Kombinacije L-treonina, L-valina, L-leucina, L-izoleucina, L-lizina i kromova pikolinata
Contributes to the reduction of the blood glucose rise when consumed together with a carbohydrate rich meal.
Pridonosi smanjenju porasta glukoze u krvi ako se uzima s jelom bogatim ugljikohidratima.
A combination of lutein and zeaxanthin
Kombinacija luteina i zeaksantina
Lutein together with zeaxanthin helps maintain clarity and contrast of sight in bright light conditions.
Lutein u kombinaciji sa zeaksantinom olakšava održavanje bistrine i kontrasta vida pri jarkoj svjetlosti.
Commission Implementing Regulation (EU) 2015/1042
Provedbena uredba Komisije (EU) 2015/1042
amending Annex II to Regulation (EC) No 250/2009 implementing Regulation (EC) No 295/2008 of the European Parliament and of the Council concerning structural business statistics, as regards the adaptation of the technical format following the revision of the classification of products by activity (CPA)
o izmjeni Priloga II. Uredbi (EZ) br. 250/2009 o provedbi Uredbe (EZ) br. 295/2008 Europskog parlamenta i Vijeća o strukturnim poslovnim statistikama u pogledu prilagodbe tehničkog formata nakon revizije klasifikacije proizvoda po djelatnostima (KPD)
Having regard to Regulation (EC) No 295/2008 of the European Parliament and of the Council of 11 March 2008 concerning structural business statistics [1], and in particular Article 11(1)(a) thereof,
uzimajući u obzir Uredbu (EZ) br. 295/2008 Europskog parlamenta i Vijeća od 11. ožujka 2008. o strukturnim poslovnim statistikama [1], a posebno njezin članak 11. stavak 1. točku (a),
Regulation (EC) No 295/2008 establishes a common framework for the collection, transmission and evaluation of European statistics on the structure, activity, competitiveness and performance of businesses in the Union.
Uredbom (EZ) br. 295/2008 uspostavlja se zajednički okvir za prikupljanje, slanje i vrednovanje europskih statističkih podataka o strukturi, djelatnostima, konkurentnosti i uspješnosti poslovanja poduzeća u Uniji.
Regulation (EC) No 451/2008 of the European Parliament and of the Council [2] establishes a statistical classification of products by activity (CPA), to meet the requirements of statistics in the Union.
Uredbom (EZ) br. 451/2008 Europskog parlamenta i Vijeća [2] uspostavlja se statistička klasifikacija proizvoda po djelatnostima (KPD) radi ispunjavanja statističkih zahtjeva u Uniji.
Annex II to Commission Regulation (EC) No 250/2009 [3] specifies the technical format and the labels for certain products for the data to be transmitted based on the CPA.
U Prilogu II. Uredbi Komisije (EZ) br. 250/2009 [3] utvrđuju se tehnički format i oznake za određene proizvode za koje se dostavljaju podaci na temelju KPD-a.
Following the entry into force of Commission Regulation (EU) No 1209/2014 [4] it is necessary to adapt Annex II to Regulation (EC) No 250/2009 with regard to the labels for certain products for the data to be transmitted based on the CPA in order to maintain the comparability and consistency with product classification standards used at international level.
Nakon stupanja na snagu Uredbe Komisije (EU) br. 1209/2014 [4] potrebno je prilagoditi Prilog II. Uredbi (EZ) br. 250/2009 s obzirom na oznake za određene proizvode za koje se dostavljaju podaci na temelju KPD-a kako bi se očuvale usporedivost i dosljednost s normama za klasifikaciju proizvoda koje se primjenjuju na međunarodnoj razini.
Annex II to Regulation (EC) No 250/2009 should therefore be amended accordingly.
Prilog II. Uredbi (EZ) br. 250/2009 stoga bi trebalo na odgovarajući način izmijeniti.
Annex II to Regulation (EC) No 250/2009 is amended in accordance with the Annex to this Regulation.
Prilog II. Uredbi (EZ) br. 250/2009 izmjenjuje se u skladu s Prilogom ovoj Uredbi.
Regulation (EC) No 451/2008 of the European Parliament and of the Council of 23 April 2008 establishing a new statistical classification of products by activity (CPA) and repealing Council Regulation (EEC) No 3696/93 (OJ L 145, 4.6.2008, p. 65).
Uredba (EZ) br. 451/2008 Europskog parlamenta i Vijeća od 23. travnja 2008. o uspostavi nove statističke klasifikacije proizvoda po djelatnostima (KPD) i o stavljanju izvan snage Uredbe Vijeća (EEZ) br. 3696/93 (SL L 145, 4.6.2008., str. 65.).
Commission Regulation (EU) No 1209/2014 of 29 October 2014 amending Regulation (EC) No 451/2008 of the European Parliament and of the Council of 23 April 2008 establishing a new statistical classification of products by activity (CPA) and repealing Council Regulation (EEC) No 3696/93 (OJ L 336, 22.11.2014, p. 1).
Uredba Komisije (EU) br. 1209/2014 оd 29. listopada 2014. o izmjeni Uredbe (EZ) br. 451/2008 Europskog parlamenta i Vijeća od 23. travnja 2008. o uspostavi nove statističke klasifikacije proizvoda po djelatnostima (KPD) i o stavljanju izvan snage Uredbe Vijeća (EEZ) br. 3696/93 (SL L 336, 22.11.2014., str. 1.).
Annex II to Regulation (EC) No 250/2009 is amended as follows:
Prilog II. Uredbi (EZ) br. 250/2009 mijenja se kako slijedi:
In point 4.2 ‘Territorial unit’, the code ‘GR’ for Greece is replaced by ‘EL’
U točki 4.2. „Teritorijalna jedinica”, oznaka „GR” za Grčku zamjenjuje se oznakom „EL”.
In point 4.9 ‘Units of data values’, in the table, a new unit ‘Square metres’ with code ‘M2’ is added.
U točki 4.9. „Jedinice vrijednosti podataka”, u tablici, dodaje se nova jedinica „kvadratni metri” s oznakom „M2”.
In point 4.10 ‘Breakdown of products’, the table is amended as follows:
U točki 4.10. „Podjela proizvoda”, tablica se mijenja kako slijedi:
for the product with code 63 12 the label ‘Web portal content’ is replaced by ‘Web portal services’.
za proizvod s oznakom 63 12 naziv „Internetski portali” mijenja se i glasi „Usluge internetskih portala”;
for the product with code 73 11 13 the label ‘Advertising design and concept development’ is replaced by ‘Advertising concept development services’
za proizvod s oznakom 73 11 13 naziv „Usluge osmišljavanja i konceptualnog razvoja promidžbenih kampanja” mijenja se i glasi „Usluge konceptualnog razvoja promidžbenih kampanja”;
the entry for the product with code 70 22 4 ‘Trademarks and franchises’ is deleted.
briše se unos za proizvod s oznakom 70 22 4 „Robni žigovi i franšize”;
for the product with code 71 11 24 the label ‘Architectural advisory services’ is replaced by ‘Building project architectural advisory services’
za proizvod s oznakom 71 11 24 naziv „Arhitektonske savjetodavne usluge” mijenja se i glasi „Arhitektonske savjetodavne usluge za građevinske projekte”.
Commission Implementing Regulation (EU) 2015/1043
Provedbena uredba Komisije (EU) 2015/1043
concerning the authorisation of the preparation of endo-1,4-beta-xylanase (EC 3.2.1.8) produced by Trichoderma citrinoviride Bisset (IM SD135) as a feed additive for chickens for fattening, turkeys for fattening, laying hens, weaned piglets, pigs for fattening and minor poultry species for fattening and for laying, and amending Regulations (EC) No 2148/2004, (EC) No 828/2007 and (EC) No 322/2009 (holder of authorisation Huvepharma NV)
o odobrenju pripravka endo-1,4-beta-ksilanaze (EC 3.2.1.8) dobivenog od Trichoderma citrinoviride Bisset (IM SD135) kao dodatka hrani za piliće za tov, pure za tov, nesilice, odbijenu prasad, svinje za tov i manje značajne vrste peradi za tov i nesenje i o izmjeni uredbi (EZ) br. 2148/2004, (EZ) br. 828/2007 i (EZ) br. 322/2009 (nositelj odobrenja Huvepharma NV)
The preparation of endo-1,4-beta-xylanase (EC 3.2.1.8) produced by Trichoderma citrinoviride Bisset (IM SD135) (formerly Trichoderma longibrachiatum) was authorised in accordance with Directive 70/524/EEC without a time limit as a feed additive for chickens for fattening by Commission Regulation (EC) No 2148/2004 [3], for turkeys for fattening by Commission Regulation (EC) No 828/2007 [4] and for laying hens and weaned piglets by Commission Regulation (EC) No 322/2009 [5].
Pripravak endo-1,4-beta-ksilanaze (EC 3.2.1.8) dobiven od Trichoderma citrinoviride Bisset (IM SD135) (bivši naziv Trichoderma longibrachiatum) odobren je u skladu s Direktivom 70/524/EEZ bez vremenskog ograničenja kao dodatak hrani za piliće za tov Uredbom Komisije (EZ) br. 2148/2004 [3], za pure za tov Uredbom Komisije (EZ) br. 828/2007 [4] i za nesilice i odbijenu prasad Uredbom Komisije (EZ) br. 322/2009 [5].
In accordance with Article 10(2) of Regulation (EC) No 1831/2003 in conjunction with Article 7 of that Regulation, an application was submitted for the re-evaluation of the preparation of endo-1,4-beta-xylanase (EC 3.2.1.8) produced by Trichoderma citrinoviride Bisset (IM SD135) (formerly Trichoderma longibrachiatum) as a feed additive for chickens for fattening, turkeys for fattening, laying hens, weaned piglets, pigs for fattening and minor poultry species for fattening and for laying.
U skladu s člankom 10. stavkom 2. Uredbe (EZ) br. 1831/2003 u vezi s člankom 7. te Uredbe podnesen je zahtjev za ponovnu procjenu pripravka endo-1,4-beta-ksilanaze (EC 3.2.1.8) dobivenog od Trichoderma citrinoviride Bisset (IM SD135) (bivši naziv Trichoderma longibrachiatum) kao dodatka hrani za piliće za tov, pure za tov, nesilice, odbijenu prasad, svinje za tov i manje značajne vrste peradi za tov i nesenje.
The applicant requested that additive to be classified in the additive category ‘zootechnical additives’.
Podnositelj zahtjeva zatražio je da se taj dodatak razvrsta u kategoriju dodataka „zootehnički dodatci”.
That application was accompanied by the particulars and documents required under Article 7(3) of Regulation (EC) No 1831/2003.
Uz navedeni zahtjev priloženi su podatci i dokumenti propisani člankom 7. stavkom 3. Uredbe (EZ) br. 1831/2003.
The European Food Safety Authority (‘the Authority’) concluded in its opinions of 31 January 2013 [6] and 10 December 2014 [7] that, under the proposed conditions of use, the preparation of endo-1,4-beta-xylanase (EC 3.2.1.8) produced by Trichoderma citrinoviride Bisset (IM SD135) (formerly Trichoderma longibrachiatum) does not have an adverse effect on animal health, human health or the environment.
Europska agencija za sigurnost hrane (dalje u tekstu „Agencija”) u svojim je mišljenjima od 31. siječnja 2013. [6] i 10. prosinca 2014. [7] zaključila da pripravak endo-1,4-beta-ksilanaze (EC 3.2.1.8) dobiven od Trichoderma citrinoviride Bisset (IM SD135) (bivši naziv Trichoderma longibrachiatum) nema negativan učinak na zdravlje životinja, zdravlje ljudi ili na okoliš.
The Authority also concluded that the use of that preparation has the potential to be efficacious in turkeys for fattening, chickens for fattening, laying hens, weaned piglets and pigs for fattening.
Agencija je zaključila i da korištenje tog pripravka može biti učinkovito kod purana za tov, pilića za tov, kokoši nesilica, odbijene prasadi i svinja za tov.
The Authority further considered that the conclusions on the efficacy can be extrapolated to minor poultry species for fattening and for laying.
Stav je Agencije i da se zaključci o učinkovitosti mogu primijeniti na manje značajne vrste peradi za tov i nesenje.
The assessment of the preparation of endo-1,4-beta-xylanase (EC 3.2.1.8) produced by Trichoderma citrinoviride Bisset (IM SD135) (formerly Trichoderma longibrachiatum) shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied.
Procjenom pripravka endo-1,4-beta-ksilanaze (EC 3.2.1.8) dobivenog od Trichoderma citrinoviride Bisset (IM SD135) (bivši naziv Trichoderma longibrachiatum) utvrdilo se da su ispunjeni uvjeti za odobrenje propisani člankom 5. Uredbe (EZ) br. 1831/2003.
Accordingly, the use of that preparation should be authorised as specified in the Annex to this Regulation.
U skladu s tim trebalo bi odobriti uporabu tog pripravka kako je definirano u Prilogu toj Uredbi.
Regulations (EC) No 2148/2004, (EC) No 828/2007 and (EC) No 322/2009 should therefore be amended accordingly.
Uredbe (EZ) br. 2148/2004, (EZ) br. 828/2007 i (EZ) br. 322/2009 trebalo bi stoga na odgovarajući način izmijeniti.
The preparation specified in the Annex, belonging to the additive category ‘zootechnical additives’ and to the functional group ‘digestibility enhancers’, is authorised as an additive in animal nutrition, subject to the conditions laid down in that Annex.
Pripravak naveden u Prilogu, koji pripada kategoriji dodataka hrani za životinje „zootehnički dodatci” i funkcionalnoj skupini „tvari za poticanje probavljivosti”, odobrava se kao dodatak hrani za životinje pod uvjetima utvrđenima u tom Prilogu.
Amendment to Regulation (EC) No 2148/2004
Izmjena Uredbe (EZ) br. 2148/2004
In Annex IV to Regulation (EC) No 2148/2004 the entry on E 1617, endo-1,4-beta-xylanase EC 3.2.1.8, is deleted.
U Prilogu IV. Uredbi (EZ) br. 2148/2004 briše se unos o E 1617, endo-1,4-beta-ksilanazi, EC 3.2.1.8.
Amendment to Regulation (EC) No 828/2007
Izmjena Uredbe (EZ) br. 828/2007
Regulation (EC) No 828/2007 is amended as follows:
Uredba (EZ) br. 828/2007 mijenja se kako slijedi:
Article 2 is deleted;
Briše se članak 2.
Annex II is deleted.
Briše se Prilog II.
Regulation (EC) No 322/2009 is amended as follows:
Uredba (EZ) br. 322/2009 mijenja se kako slijedi:
The preparation specified in the Annex, and feed containing that preparation, which are produced and labelled before 21 January 2016 in accordance with the rules applicable before 21 July 2015 may continue to be placed on the market and used until the existing stocks are exhausted.
Pripravak naveden u Prilogu i hrana za životinje koja taj pripravak sadržava, a koji su proizvedeni i označeni prije 21. siječnja 2016. u skladu s pravilima primjenjivima prije 21. srpnja 2015., mogu se nastaviti stavljati na tržište i upotrebljavati dok se ne potroše postojeće zalihe.
Commission Regulation (EC) No 2148/2004 of 16 December 2004 concerning the permanent and provisional authorisations of certain additives and the authorisation of new uses of an additive already authorised in feedingstuffs (OJ L 370, 17.12.2004, p. 24).
Uredba Komisije (EZ) br. 2148/2004 od 16. prosinca 2004. o trajnim i privremenim odobrenjima određenih dodataka hrani za životinje i odobrenju novih korištenja dodatka već odobrenog u hrani za životinje (SL L 370, 17.12.2004., str. 24.).
Commission Regulation (EC) No 828/2007 of 13 July 2007 concerning the permanent and provisional authorisation of certain additives in feedingstuffs (OJ L 184, 14.7.2007, p. 12).
Uredba Komisije (EZ) br. 828/2007 od 13. srpnja 2007. o trajnom i privremenom odobrenju određenih dodataka hrani za životinje (SL L 184, 14.7.2007., str. 12.).
Commission Regulation (EC) No 322/2009 of 20 April 2009 concerning the permanent authorisations of certain additives in feedingstuffs (OJ L 101, 21.4.2009, p. 9).
Uredba Komisije (EZ) br. 322/2009 od 20. travnja 2009. o trajnim odobrenjima određenih dodataka hrani za životinje (SL L 101, 21.4.2009., str. 9.).
EFSA Journal 2013; 11(2):3105.
EFSA Journal 2013.; 11(2):3105.
EFSA Journal 2015; 13(1):3969.
EFSA Journal 2015.; 13(1):3969.
Units of activity/kg of complete feedingstuff with a moisture content of 12 %
Jedinice aktivnosti po kg potpune krmne smjese s udjelom vlage od 12 %
Preparation of endo-1,4-beta-xylanase (EC 3.2.1.8) produced by Trichoderma citrinoviride Bisset (IM SD135) with a minimum activity of 6000 EPU [1]/g
Pripravak endo-1,4-beta-ksilanaze (EC 3.2.1.8) dobiven od Trichoderma citrinoviride Bisset (IM SD135) najmanje aktivnosti od 6000 EPU [1]/g
(solid and liquid form)
(kruti i tekući oblik)
endo-1,4-beta-xylanase (EC 3.2.1.8) produced by Trichoderma citrinoviride Bisset (IM SD135)
endo-1,4-beta-ksilanaza (EC 3.2.1.8) dobivena od Trichoderma citrinoviride Bisset (IM SD135)
Analytical method [2]For characterisation of endo-1,4-beta-xylanase activity:
Analitička metoda [2]Za opis aktivnosti endo-1,4-beta-ksilanaze:
colorimetric method measuring water soluble dye released by action of endo-1,4-β-xylanase from azurine cross-linked wheat arabinoxylan substrates.
kolorimetrijska metoda kojom se mjeri boja topiva u vodi koja se djelovanjem endo-1,4-beta-ksilanaze oslobađa iz supstrata križno vezanog azurin pšeničnog arabinoksilana.
Turkeys for fattening and minor poultry species for fattening
Pure za tov i manje značajne vrste peradi za tov
For use in feed rich in starch and non-starch polysaccharides (mainly beta- arabinoxylans).
Upotrebljava se u hrani za životinje bogatoj škrobnim i neškrobnim polisaharidima (uglavnom beta-arabinoksilani).
For use in weaned piglets until approximately 35 kg.
Upotrebljava se kod odbijene prasadi do otprilike 35 kg težine.
21 July 2025
21. srpnja 2025.
Minor poultry species for laying
Manje značajne vrste peradi za nesenje
1 EPU is the amount of enzyme which releases 0,0083 μmol of reducing sugars (xylose equivalent) per minute from oat spelt xylan at pH 4,7 and 50 °C.
1 EPU je količina enzima koja oslobađa 0,0083 mikromola reducirajućih šećera (ekvivalenti ksiloze) iz ksilana zobi po minuti pri pH 4,7 i 50 °C.
Details of the analytical methods are available at the following address of the Reference Laboratory: https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports
Podatci o analitičkim metodama dostupni su na sljedećoj adresi referentnog laboratorija: https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports